Article Type

76 - 90 of 246 Results       Clear All

Virologist Says 2nd COVID Booster Shot for Everyone Could Be Advised in the Fall

Gladstone in the News March 30, 2022

Virologist Says 2nd COVID Booster Shot for Everyone Could Be Advised in the Fall

ABC News—The FDA recently announced that they would authorize a second COVID-19 vaccine booster shot for people 50 and older, and those 12 and older who are immunocompromised. Senior Investigator Warner Greene explains that the second booster can protect people who don’t have vigorous immune systems from infection, and predicts that it may be more broadly recommended for all adults in the months to come.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Do You Need a 4th Dose of a COVID-19 Vaccine? There’s No One-Size-Fits-All Answer

Gladstone in the News March 30, 2022

Do You Need a 4th Dose of a COVID-19 Vaccine? There’s No One-Size-Fits-All Answer

CBC—The FDA recently authorized a fourth dose of the Pfizer-BioNTech COVID-19 vaccine for all individuals over aged 50, and for those 12 and older with immunodeficiencies. Melanie Ott, director of the Gladstone Institute of Virology, explains that whereas a fourth shot may not be urgently necessary for individuals who are young and healthy, she does encourage those eligible to ensure that they get their third shot (first booster).

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Highly-Transmissible COVID Subvariant Increasing in CA, but Expert ‘Doubts’ Lockdowns Will Be Needed

Gladstone in the News March 16, 2022

Highly-Transmissible COVID Subvariant Increasing in CA, but Expert ‘Doubts’ Lockdowns Will Be Needed

ABC News—A sub-variant of Omicron known as BA.2 is causing a spike in COVID-19 cases in Europe, and is predicted to become the globally dominant variant in the coming weeks. However, Senior Investigator Warner Greene says that vaccinated and boosted individuals are still well protected against serious illness, and spread of this new variant is unlikely to lead to new lockdowns.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Three Ways to Strengthen a Collaborative Culture

Gladstone in the News March 9, 2022

Three Ways to Strengthen a Collaborative Culture

The APQC Blog—Gladstone President Deepak Srivastava, MD, President Emeritus Robert Mahley, MD, PhD, Senior Investigators Melanie Ott, MD, PhD, and Katie Pollard, PhD, explain how they and others at Gladstone create a collaborative research culture and plan to balance safety with the chance encounters that fuel creativity.

Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Infectious Disease Huang Lab Ott Lab Pollard Lab Srivastava Lab Weinberger Lab

Disease in a Dish: What Mini-Hearts and Other Organs Reveal about Long COVID

Gladstone in the News March 9, 2022

Disease in a Dish: What Mini-Hearts and Other Organs Reveal about Long COVID

San Jose Mercury News—Senior Investigators Melanie Ott, MD, PhD, and Bruce Conklin, MD, recount how they used miniature balls of beating heart cells called organoids to study the effects of COVID-19 on the heart. The heart cells were derived from a person's skin cells, thanks to technology pioneered by Senior Investigator and Nobel Laureate Shinya Yamanaka, MD, PhD.

Gladstone Experts Stem Cell Core COVID-19 Cardiovascular Disease Data Science and Biotechnology Infectious Disease Conklin Lab Ott Lab Yamanaka Lab Organoids

Omicron Could Be the Beginning of the End of the COVID-19 Pandemic

Gladstone in the News January 26, 2022

Omicron Could Be the Beginning of the End of the COVID-19 Pandemic

Time—The Omicron variant of SARS-CoV-2 has spread around the world at an alarming rate, but some scientists think the variant might actually be a sign of hope. Nadia Roan explains that widespread infection may lead to widespread immunity, which could help turn the pandemic virus into an endemic virus. Warner Greene posits that the best-case scenario is that the virus will weaken, continuing to spread but without causing severe disease.

Gladstone Experts COVID-19 Infectious Disease Greene Lab Roan Lab

Moderna Announces People May Need 2nd Vaccine Booster, but Many Doctors Disagree

Gladstone in the News January 10, 2022

Moderna Announces People May Need 2nd Vaccine Booster, but Many Doctors Disagree

ABC News—COVID-19 vaccine maker Moderna recently announced that individuals might need a fourth shot to stay safe in the ongoing pandemic. Gladstone virologist Warner Greene argues that an additional dose of the available vaccine may not be ideal, and that future boosters should be designed to specifically protect against emerging strains of the virus.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Indoor Dining May Once Again Be Too Risky Due to Omicron, Bay Area Health Experts Warn

Gladstone in the News January 5, 2022

Indoor Dining May Once Again Be Too Risky Due to Omicron, Bay Area Health Experts Warn

San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, recommends that people limit indoor dining, especially if they are over 65 or otherwise at elevated risk for COVID-19, while the Omicron wave washes over the Bay Area.

Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab

New COVID-19 Nasal Spray Therapy Aims to ‟Reduce Viral Load in the Lungs by 100-Fold”

Gladstone in the News December 15, 2021

New COVID-19 Nasal Spray Therapy Aims to ‟Reduce Viral Load in the Lungs by 100-Fold”

abc7 NEWS—Senior Investigator Leor Weinberger, PhD, and Research Investigator Sonali Chaturvedi, PhD, explain their work on a therapy that sharply reduces viral load in the nose of hamsters after a single administration and could add a promising new tool to the therapeutic arsenal against COVID-19.

Gladstone Experts COVID-19 Infectious Disease Weinberger Lab

Virus-Hijacking COVID-19 Drug from Gladstone Researchers Slows Down Variants, Expects Clinical Trial Early Next Year

Gladstone in the News December 14, 2021

Virus-Hijacking COVID-19 Drug from Gladstone Researchers Slows Down Variants, Expects Clinical Trial Early Next Year

San Francisco Business Times—Senior Investigator Leor Weinberger, PhD, pioneered a new class of antivirals called therapeutic interfering particles (TIPs), which were recently shown to be effective against SARS-CoV-2 in animal models. The approach is now being developed by a startup company and will be headed to clinical trials.

Gladstone Experts COVID-19 Center for Cell Circuitry Infectious Disease Weinberger Lab

More News

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media